Professional Documents
Culture Documents
1
5/15/21
Neurology
Neurology
• Anesthesia
• Parkinson’s Dr0gs
• Alzheimer's Dr0gs
2
5/15/21
Anesthesia
Understand vocabulary:
• Potency ↔ Lipid Solubility
USMLE Test Taking
Strategy: • Potency ↔ Minimum Alveolar
Anesthesiology
Questions Concentration (MAC)
• Blood Solubility ↔ Induction
3
5/15/21
10
11
M inim um Alveolar
Potency
Concentration
12
4
5/15/21
Understand vocabulary:
• Potency ↔ Lipid Solubility
USMLE Test Taking
Strategy: • Potency ↔ Minimum Alveolar
Anesthesiology
Questions Concentration (MAC)
13
14
§ N 2O
§ It fills air filled
spaces quickly à do
not use it in
pneum othorax.
15
5
5/15/21
Anesthestic Agents
Anesthesia
Principles
Specific Names -ane (halothane,
sevoflurane, etc.)
16
17
18
6
5/15/21
Malignant hyperthermia
Autonomic Instab
RyR mutation
Trigger with ⬆ CPK
anesthesia Increased intra-
⬆ ETCO2 +
cytosolic Ca2+
lactate
19
20
21
7
5/15/21
22
23
24
8
5/15/21
Cerebral
Autoregulation
25
Hypercapnea Hypocapnea
• High CO2 à cerebral • Low CO2 à cerebral
vasodilation. vasoconstriction.
• Increases cerebral • Decreases cerebral
blood flow. blood flow.
26
27
9
5/15/21
28
H yG u ru H ig h -Y ield
G A B A A g e n ts
• ⬆ High lipid solubility (i.e. goes into tissues)
• Thiopental • ⬆ High volume of distribution
G A B A A g e n ts
• ⬆ f requency of GABA channel opening
• M idazolam
G A B A A g e n ts
• ⬆ GABA à hypotension (dec SVR)
• Propofol • Lipophillic à rapidly goes into fat
G A B A A g e n ts
• ⬆ GABA à inhibits Ca 2+ channels
GABA Agents • Gabapentin • Neuropathic pain (tingling)
G A B A A g e n ts
• ⬆ GABA à Blocks Na 2+ channels
• Topiram ate • Sedation, Stones, Skinny
G A B A A g e n ts
• ⬆ duration of GABA channel opening
• Barbiturates • Induces CYP
29
30
10
5/15/21
31
Parkinson’s Drugs
32
33
11
5/15/21
Contrasting Pathologies
Alzheimer’s
Parkinson’s • ADL decline
• Tremor at rest, • Cortical atrophy
bradykinesia • Aβ amyloid (21) à
• Loss of pigment in amyloid hemorrhage
substantia nigra • Neurofib tangles à
• ɑ - synuclein (Lewy hyperPO4 tau
Body) § Lew y Body Dem entia (frontotemporal
§ C ortical ɑ
synuclein dementia)
inclusions.
34
Thalam us
Striatum
Substantia Nigra
Pars Com pacta
Globus Pallidus Interna
§ Globus Pallidus at a basal level
Substantia Nigra Reticularis
inhibits the thalamus.
35
36
12
5/15/21
Thalam us
Striatum
Substantia Nigra
Pars Com pacta
Globus Pallidus Interna
§ Globus Pallidus at a basal level
Subthalam ic Nuclei Substantia Nigra Reticularis
inhibits the thalamus.
37
38
Parkinsonian Pharmacology
On-off phenomena
SE
39
13
5/15/21
40
41
Parkinsonian pharmacology
Rasagiline
42
14
5/15/21
43
review of agents
▸ To decrease peripheral conversion of L-DOPA which
agent is likely prescribed?
▸ Carbidopa
▸ What two classes of medications prevent the breakdown of Dopa
or Dopamine?
▹ COM-T Inhibitors – Entacapone & Tolcapone
▹ MAO-B Inhibitors – Rasagiline & Seligiline
44
Amantadine
• Livedo Reticularis
• Amantadine à
• NMDA Antagonist
• Increases Dopamine at synaptic cleft
• Can cause prolonged QT
• Flu virus à prevents uncoating.
45
15
5/15/21
Alzheimer’s Drugs
46
47
48
16
5/15/21
Pathophysiology
Neurology Aspiration PNA
Mechanism
49
Alzheimer's Pharmacology
D ecrease in A ch
G lob al C ereb ral A trop h y
Loss of A D Ls
Specific Names Donepezil
Rivastigmine
Galantamine
SE Wet
50
Alzheimer pharmacology
51
17
5/15/21
⬆ book on anti-NM DA
encephalitis 🔥 🧠
52
53
Contrasting ANS
Cholinomimetic Anti-Cholinergic
• Wet: diarrhea, • Dry: urinary
lacrimation, retention, abdominal
bronchorrhea pain, skin flushing
• Bronchoconstriction • Bronchodilation
• Bradycardia • Tachycardia
• Small Pupils • Large Pupils
§ U SM LE Test Taking:
§ Pupils & Vital Signs
54
18
5/15/21
55
review of agents
▸ A patient who overdosed on rivastigmine is most likely to have which changes in heart rate?
▸ Bradycardia
▸ 32 yo woman complains of double vision. She says this occurs in the afternoon. Exam
shows weakness of her eyes when asked to actively keep them elevated. What is the
mechanism behind the likely pathology?
▹ Antibodies to nAchR à Myasthenia Gravis
■ Key USMLE question: progressive weakness + bulbar symptoms
▸ What is the role of chest imaging for this type 2 hypersensitivity pathology?
▹ Thymoma à generate the anti-bodies.
▸ In summary:
▹ Acetylcholinesterase inhibitors are used for Alzheim er’s & Myasthenia Gravis.
56
Psychiatry
57
19
5/15/21
Psychiatry
• Anti-Psychotics
• Anti-Depressants
58
Anti-Psychotics
59
• B. Nigrostriatal
• C. Mesolimbic
• D. Tubuloinfundibular
60
20
5/15/21
Pharmacological
Psychiatry Dopamine Pathways
Side Effect
61
62
Psychosis Pharmacology
Hallucinations + Delusions
*Haloperidol
+ Disorganized thinking
Specific Names *Fluphenazine
Manic Episodes **Clozapine, **Olanzapine,
**Risperidone, **Quetiapine
Delirium
*EPS
SE **Metabolic Syndrome
NMS
63
21
5/15/21
64
65
§ Treatment
Neuroleptic malignant syndrome
§ Dantrolene
§ Ergot
derivatives
Autonomic Instab
Trigger with anti- Dopamine ⬆ Muscle rigidity
psychotic (1st gen) Antagonism (CPK)
⬆ Hyperthermia
66
22
5/15/21
Pharmacological
Psychiatry Neuroleptic Malignant Syndrome
Side Effect
67
68
Antipsychotics
Aripriprazole,
Clozapine, Olanzapine,
Low Potency High Potency Quetiapine,
Risperidone,
Ziprasidone
69
23
5/15/21
• D. Thyroid Panel
• E. BUN : Cr ratio
70
Pharmacological
Psychiatry Metabolic Syndrome
Side Effect
71
72
24
5/15/21
review of agents
▸ Neck stiffness, and inability to relax in a schizophrenic
on a first-gen antipsychotic. What is the MOA of the
likely Rx?
▹ Benztropine à Acute dystonia
73
review of agents
▸ Slow narrow gait, tremor at rest, flat affect, drooling in a
schizophrenic on a first gen-antipsychotic. What is the
diagnosis?
▹ Pseudo-parkinsonism
74
Antipsychotics
§ USMLE Point
§ 2nd generation
work on many
receptors à know
SE
1st generation 2nd generation
Aripriprazole,
Clozapine, Olanzapine,
Low Potency High Potency Quetiapine,
Risperidone,
Ziprasidone
75
25
5/15/21
76
77
Agranulocytosis
• Ganciclovir
• Colchicine § Watch for
Integrative recurrent
USMLE • PTU/Methimazole infections à
Pharmacology • Clozapine sore throat,
myocarditis
• Carbamazepine
78
26
5/15/21
Anti-Depressants
79
SSRI Pharmacology
80
• B. Histamine
• C. Tryptophan
• D. Methionine
81
27
5/15/21
Pharmacological
Psychiatry Serotonin Syndrome
Side Effect
82
Integrative
USMLE
Biochemistry
83
Serotonin Atypical
SSRI SNRI antagonists Antidepressants
84
28
5/15/21
85
Venlafaxine
Duloxetine
86
Trazodone
87
29
5/15/21
Antidepressants • A fem ale low BMI + m etabolic • Buproprion lowers the seizure
alkalosis + callous on knuckles? threshold.
• Pt who fails SSRI à switch to • Used for pt who has
m ed for MDD? im potence from SSRI.
88
89
§ TC A overdose:
§ Blocks fast N a
channels.
§ TC A:
§ Im ipram ine w e use
for nocturnal
enuresis.
§ C lom ipram ine can
cause high PRL.
90
30
5/15/21
pulmonary
91
Pulmonary
• Asthma Medications
• Pulmonary Hypertension Medications
• Anti-Allergic Agents
92
Asthma
93
31
5/15/21
94
95
•
• Allergen • CD4+ IL-
5
• TH2
• Eosinophils
96
32
5/15/21
§ ⬇ inflammation
§ ⬇ wet
parasympathetics
β2 agonists
Inhaled Anti-Leukotriene Muscarinic
Steroids Agents antagonists
Albuterol
Budesonide
Terbutaline Montelukast Tiotropium
Fluticasone
Salmeterol Zafirlukast Ipratropium
Mometasone
Formoterol
97
Asthma Pharmacology
Decrease B2
Class Effect or Big Picture hyperresponsiveness
• Bronchial SABA
hyperresponsiveness LABA
Specific Names ICS
• Mucus plugging Anti-Leukotriene
• Inflammation Anti-Cholinergic
SE Tachycardia + Tremor
98
• B. Live failure
• C. Anaphylaxis
• D. Interventricular hemorrhage
99
33
5/15/21
100
Albuterol
Terbutaline § LABA meds can cause
cardiotoxicity + tachyphylaxis
Salmeterol
Formoterol
101
• M3 receptors increase:
• β2 receptors increase:
• bronchial secretions
• bronchodilation
• smooth muscle airway
contraction
102
34
5/15/21
• B. Ipratropium
• C. Montelukast
• D. Fluticasone
103
Steroids
• Im pairm ent of fibroblast activity
• Skin atrophy for
à collagen synthesis ⬇
topical steroids
Budesonide
Fluticasone
Mometasone
104
Gastrointestinal
Hypertension
• Peptic ulcers &
hemorrhage • Increased upregulation
of sympathomimetic
• Reduced AA receptors.
pathway à ⬇ PG
Metabolic Derangements
MSK • ⬆ lipolysis
• Avascular necrosis • ⬆ gluconeogenesis
• Proximal muscle weakness • ⬆ proteolysis
• Osteoporosis à • ⬆ insulin resistance
• RANK-L osteoclasts
• Growth plate ⬇
105
35
5/15/21
106
Membrane
Phospholipids
Arachidonic Acid
LOX Prostaglandins
Anti-Leukotriene
Agents
Leukotrienes: TXA2, PGD2, PGI2 & PGE2
PGF2ɑ
LTB4: PMN ⬆
LTC4 & LTE4: Bronchoconstriction Bronchodilation Vasodilation
Montelukast bronchospasm +
permeability
Zafirlukast
107
108
36
5/15/21
Pulmonary Htn
109
Chronic hypoxic
pulmonary
vasoconstriction Right ventricular
Increased PVR afterload ⬆
Airway smooth
muscle
hypertrophy
§ U SM LE Point:
§ Increased R V pressures
§ Tricuspid regurgitation
§ Jugular venous
distension
§ H epatom egaly
§ Peripheral edem a
110
111
37
5/15/21
Decrease PVR
Class Effect or Big Picture
112
USMLE Questions:
q Bosenten à
ü Endothelin antagonist
ü Liver toxicity
q Nitric Oxide à
ü ⬆ cGMP (iNO)
ü Sildenafil à PDE-5
ü ⬆ cGMP
q Prostacyclin à
ü Epoprostenol
ü Iloprost
ü Treprostinil
113
Anti-Allergy
114
38
5/15/21
H1: H2 :
• Anti-allergy o Anti-acid
o 1st generation o ECL cells à stimulate
o Cross BBB parietal à H/K ATPase
o Gq o Gs
115
H1 anti-histamines
Diphenhydramine
Promethazine
Sedation
1st generation
Anti-Allergy
Chlorpheniramine
Hydroxyzine
Cyproheptadine
Loratadine
2nd generation More Anti-Allergy Cetirizine
Fexofenadine
116
Reproductive
117
39
5/15/21
Reproductive
• Selective EstAogen Receptor Modulators
(SERMs)
• Testosterone Agents
118
119
SERMs
Decrease effects of
Class Effect or Big Picture Estrogen
• Estrogen à
endometrial or breast Specific Names Tamoxifen, Raloxifene,
hyperplasia à dysplasia Clomiphene
120
40
5/15/21
• T4 / T3
• (1,25) Vitamin D
121
122
Pharmacological
Reproductive Selective Estrogen Receptor Modulators
Mechanism
123
41
5/15/21
124
125
126
42
5/15/21
Pharmacological
Reproductive Selective Estrogen Receptor Modulators
Mechanism
127
Testosterone Agents
128
Testosterone Agents
• Inhibition of RAAS
• Spironolactone
• Polycystic ovarian syndrom e
• Decrease testosterone synthesis in adrenals.
• Ketoconazole
• Inhibits fungal sterol synthesis
129
43
5/15/21
Gastroenterology
130
Acid Suppression
131
Gastroenterology
• Acid Suppression
132
44
5/15/21
Gastrointestinal physiology
133
134
135
45
5/15/21
Pharmacological
Gastroenterology Cimetidine
Mechanism
136
137
138
46
5/15/21
Normal Flora
Recent Abx Use disruption Stool PCR
(Clindamycin)
Toxin A & B à Oral vancomycin
PPI cytoskeletal
damage IV Metronidazole
Hospitalization
Pseudomembrane
§ Presentation on the
U SM LE:
§ w atery diarrhea
§ leukocytosis
§ abdom inal pain
139
47